Amvuttra (vutrisiran)

pCPA File Number: 22562
Negotiation Status:
Active Negotiation
Indication(s):
Hereditary transthyretin mediated amyloidosis (hATTR amyloidosis)
Sponsor/Manufacturer:
Alnylam Netherlands B.V.
CDA-AMC Project Number:
SR0801-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable